230 related articles for article (PubMed ID: 32117736)
1. A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients.
Yang H; Lin HC; Liu H; Gan D; Jin W; Cui C; Yan Y; Qian Y; Han C; Wang Z
Front Oncol; 2020; 10():81. PubMed ID: 32117736
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of ceRNA network reveals functional lncRNAs associated with independent recurrent prognosis in colon adenocarcinoma.
Mao Y; Lv J; Jiang L; Wang Y
Cancer Cell Int; 2021 Jul; 21(1):352. PubMed ID: 34225739
[TBL] [Abstract][Full Text] [Related]
3. Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma.
Jin LP; Liu T; Meng FQ; Tai JD
BMC Cancer; 2020 Oct; 20(1):968. PubMed ID: 33028275
[TBL] [Abstract][Full Text] [Related]
4. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
5. Screening of Significant Biomarkers Related to Prognosis of Cervical Cancer and Functional Study Based on lncRNA-associated ceRNA Regulatory Network.
Ding H; Zhang L; Zhang C; Song J; Jiang Y
Comb Chem High Throughput Screen; 2021; 24(3):472-482. PubMed ID: 32729415
[TBL] [Abstract][Full Text] [Related]
6. Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma.
Poursheikhani A; Abbaszadegan MR; Nokhandani N; Kerachian MA
BMC Med Genomics; 2020 Jul; 13(1):108. PubMed ID: 32727450
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
[TBL] [Abstract][Full Text] [Related]
8. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
[TBL] [Abstract][Full Text] [Related]
9. Screening key prognostic factors and constructing survival prognostic risk prediction model based on ceRNA network in early lung adenocarcinoma.
Bai J; Zhu X; Zhang J; Bulin B
Transl Cancer Res; 2021 Nov; 10(11):4652-4663. PubMed ID: 35116321
[TBL] [Abstract][Full Text] [Related]
10. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
11. Screening of m6A gene-related lncRNAs in colon adenocarcinoma and construction of a prognostic prediction model.
Jin LP; Sun YW; Liu T; Tai JD
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10462-10471. PubMed ID: 37975370
[TBL] [Abstract][Full Text] [Related]
12. Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma.
Zhang J; Wu Y; Mu J; Xin D; Wang L; Fan Y; Zhang S; Xu Y
Front Oncol; 2022; 12():954226. PubMed ID: 36203430
[TBL] [Abstract][Full Text] [Related]
13. Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma.
Chen F; Li Z; Deng C; Yan H
J Transl Med; 2019 Aug; 17(1):299. PubMed ID: 31470869
[TBL] [Abstract][Full Text] [Related]
14. A Risk Score System Based on the Methylation Levels of 15 RNAs in Breast Cancer.
Sun Y; Wang R
Cancer Biother Radiopharm; 2022 Oct; 37(8):697-707. PubMed ID: 33571027
[No Abstract] [Full Text] [Related]
15. Integrative Proteo-Genomic Analysis for Recurrent Survival Prognosis in Colon Adenocarcinoma.
Ai F; Wang W; Liu S; Zhang D; Yang Z; Liu F
Front Oncol; 2022; 12():871568. PubMed ID: 35847888
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and Predicted Significance of FENDRR in Colon and Rectum Adenocarcinoma.
Yang F; Sun S; Yang F
Front Oncol; 2021; 11():668595. PubMed ID: 34621665
[TBL] [Abstract][Full Text] [Related]
17. A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer.
Chen Q; Hu Z; Zhang X; Wei Z; Fu H; Yang D; Cai Q
Open Med (Wars); 2021; 16(1):540-552. PubMed ID: 33869776
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X
J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713
[TBL] [Abstract][Full Text] [Related]
19. Five-long non-coding RNA risk score system for the effective prediction of gastric cancer patient survival.
Hu Z; Yang D; Tang Y; Zhang X; Wei Z; Fu H; Xu J; Zhu Z; Cai Q
Oncol Lett; 2019 May; 17(5):4474-4486. PubMed ID: 30988816
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.
Tang X; Lin Y; He J; Luo X; Liang J; Zhu X; Li T
World J Surg Oncol; 2022 Mar; 20(1):74. PubMed ID: 35264195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
